Açık Akademik Arşiv Sistemi

The effects of zoledronic acid on ECG: a prospective study on patients with bone metastatic cancer

Show simple item record

dc.contributor.authors Demirtas, D; Bilir, C; Demirtas, AO; Engin, H;
dc.date.accessioned 2020-02-27T08:26:58Z
dc.date.available 2020-02-27T08:26:58Z
dc.date.issued 2017
dc.identifier.citation Demirtas, D; Bilir, C; Demirtas, AO; Engin, H; (2017). The effects of zoledronic acid on ECG: a prospective study on patients with bone metastatic cancer. CLINICAL CASES IN MINERAL AND BONE METABOLISM, 14, 39-35
dc.identifier.issn 1724-8914
dc.identifier.uri https://doi.org/10.11138/ccmbm/2017.14.1.035
dc.identifier.uri https://hdl.handle.net/20.500.12619/65901
dc.description.abstract Conclusion. There were no significant alterations in ECG in the acute period, indicated that ZA had no arrhythmia potential in the early period in patients with no underlying cardiac disease. However: patients receiving ZA should be monitored more closely because of the risk of arrhythmia which may ensue due to hypocalcemia, hypomagnesemia, or other chemotherapeutics.
dc.language English
dc.publisher CIC EDIZIONI INT
dc.subject Endocrinology & Metabolism
dc.title The effects of zoledronic acid on ECG: a prospective study on patients with bone metastatic cancer
dc.type Article
dc.identifier.volume 14
dc.identifier.startpage 35
dc.identifier.endpage 39
dc.contributor.department Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor Bilir, Cemil
dc.relation.journal CLINICAL CASES IN MINERAL AND BONE METABOLISM
dc.identifier.wos WOS:000426915300006
dc.identifier.doi 10.11138/ccmbm/2017.14.1.035
dc.identifier.eissn 1971-3266
dc.contributor.author Derya Demirtas
dc.contributor.author Bilir, Cemil
dc.contributor.author Abdullah Orhan Demirtas
dc.contributor.author Huseyin Engin


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record